Physician profile
Ernest E Cope
NPI 1528032281
$825.72
in general payments reported to CMS, 2019-2025
14 companies · $89.15 in 2025
The $89.15 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $85.76 · 2021: $47.98 · 2022: $110 · 2023: $302 · 2024: $84.21 · 2025: $89.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $188.93 | 2019-2025 | Monovisc, Orthovisc |
| Stryker Corporation | $167.68 | 2023-2025 | Gamma, Hoffmann, Spinejack |
| Globus Medical, INC. | $71.57 | 2023 | Excelsiusgps Robotic Navigation System |
| Si-Bone, INC. | $56.98 | 2022 | |
| Carbofix Orthopedics INC | $56.16 | 2020 | |
| Abbott Laboratories | $55.77 | 2025 | Octrode, Eterna |
| Ferring Pharmaceuticals INC. | $55.01 | 2023-2024 | Euflexxa |
| Medtronic, INC. | $49.70 | 2024 | Intellis Adaptivestim |
| Wound Management Technologies, INC | $33.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.42 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.31 | 2021 | |
| Ermi LLC | $18.25 | 2023 | |
| Djo, LLC | $17.72 | 2021 | |
| Organogenesis INC. | $13.73 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.